Cargando…
Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma
For head and neck squamous cell carcinoma (HNSCC), the local invasion and distant metastasis represent the predominant causes of mortality. Targeted inhibition of chemokines and their receptors is an ongoing antitumor strategy established on the crucial roles of chemokines in cancer invasion and met...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854715/ https://www.ncbi.nlm.nih.gov/pubmed/35177591 http://dx.doi.org/10.1038/s41419-022-04610-5 |
_version_ | 1784653489387864064 |
---|---|
author | Ling, Zihang Li, Wei Hu, Jiaqi Li, Yuanyuan Deng, Miao Zhang, Siyuan Ren, Xianyue Wu, Tong Xia, Juan Cheng, Bin Tao, Xiaoan |
author_facet | Ling, Zihang Li, Wei Hu, Jiaqi Li, Yuanyuan Deng, Miao Zhang, Siyuan Ren, Xianyue Wu, Tong Xia, Juan Cheng, Bin Tao, Xiaoan |
author_sort | Ling, Zihang |
collection | PubMed |
description | For head and neck squamous cell carcinoma (HNSCC), the local invasion and distant metastasis represent the predominant causes of mortality. Targeted inhibition of chemokines and their receptors is an ongoing antitumor strategy established on the crucial roles of chemokines in cancer invasion and metastasis. Herein, we showed that C-C motif chemokine ligand 2 (CCL2)- C-C motif chemokine receptor 4 (CCR4) signaling, but not the CCL2- C-C motif chemokine receptor 2 (CCR2) axis, induces the formation of the vav guanine nucleotide exchange factor 2 (Vav2)- Rac family small GTPase 1 (Rac1) complex to activate the phosphorylation of myosin light chain (MLC), which is involved in the regulation of cell motility and cancer metastasis. We identified that targeting CCR4 could effectively interrupt the activation of HNSCC invasion and metastasis induced by CCL2 without the promoting cancer relapse observed during the subsequent withdrawal period. All current findings suggested that CCL2-CCR4-Vav2-Rac1-p-MLC signaling plays an essential role in cell migration and cancer metastasis of HNSCC, and CCR4 may serve as a new potential molecular target for HNSCC therapy. |
format | Online Article Text |
id | pubmed-8854715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88547152022-03-03 Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma Ling, Zihang Li, Wei Hu, Jiaqi Li, Yuanyuan Deng, Miao Zhang, Siyuan Ren, Xianyue Wu, Tong Xia, Juan Cheng, Bin Tao, Xiaoan Cell Death Dis Article For head and neck squamous cell carcinoma (HNSCC), the local invasion and distant metastasis represent the predominant causes of mortality. Targeted inhibition of chemokines and their receptors is an ongoing antitumor strategy established on the crucial roles of chemokines in cancer invasion and metastasis. Herein, we showed that C-C motif chemokine ligand 2 (CCL2)- C-C motif chemokine receptor 4 (CCR4) signaling, but not the CCL2- C-C motif chemokine receptor 2 (CCR2) axis, induces the formation of the vav guanine nucleotide exchange factor 2 (Vav2)- Rac family small GTPase 1 (Rac1) complex to activate the phosphorylation of myosin light chain (MLC), which is involved in the regulation of cell motility and cancer metastasis. We identified that targeting CCR4 could effectively interrupt the activation of HNSCC invasion and metastasis induced by CCL2 without the promoting cancer relapse observed during the subsequent withdrawal period. All current findings suggested that CCL2-CCR4-Vav2-Rac1-p-MLC signaling plays an essential role in cell migration and cancer metastasis of HNSCC, and CCR4 may serve as a new potential molecular target for HNSCC therapy. Nature Publishing Group UK 2022-02-17 /pmc/articles/PMC8854715/ /pubmed/35177591 http://dx.doi.org/10.1038/s41419-022-04610-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Ling, Zihang Li, Wei Hu, Jiaqi Li, Yuanyuan Deng, Miao Zhang, Siyuan Ren, Xianyue Wu, Tong Xia, Juan Cheng, Bin Tao, Xiaoan Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma |
title | Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma |
title_full | Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma |
title_fullStr | Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma |
title_full_unstemmed | Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma |
title_short | Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma |
title_sort | targeting ccl2-ccr4 axis suppress cell migration of head and neck squamous cell carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854715/ https://www.ncbi.nlm.nih.gov/pubmed/35177591 http://dx.doi.org/10.1038/s41419-022-04610-5 |
work_keys_str_mv | AT lingzihang targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT liwei targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT hujiaqi targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT liyuanyuan targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT dengmiao targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT zhangsiyuan targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT renxianyue targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT wutong targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT xiajuan targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT chengbin targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma AT taoxiaoan targetingccl2ccr4axissuppresscellmigrationofheadandnecksquamouscellcarcinoma |